Position in BMY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$7,233,211
-$147,712 QoQ
Shares Held
125,533
+3.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#452
of 2,506 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ellsworth Advisors, LLC holds $34,290,994 across 6 Drug Manufacturers - General names. BMY ranks #3 (21.1% of the industry book) .
All Filings in BMY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,233,211 | 125,533 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $7,380,923 | 121,697 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $6,252,455 | 115,915 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $4,779,562 | 105,977 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $4,698,064 | 101,492 | Shares | Sole | 2025-07-23 | |
| 2023-06-30 | $679,340 | 10,623 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $702,872 | 10,141 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $624,094 | 8,674 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $491,942 | 6,920 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $497,035 | 6,455 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $229,241 | 3,139 | Shares | Sole | 2022-04-21 | |
| 2021-06-30 | $224,314 | 3,357 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $215,841 | 3,419 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $224,424 | 3,618 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $216,260 | 3,587 | Shares | Sole | 2021-02-03 | |
| 2020-06-30 | $210,915 | 3,587 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||